Category: Finance
Eye on Lithium: You lose some you Winsome? WR1 gives off Tier 1 vibes
Yep, the lithium “spod price” appears to in a bit of a funk at the moment. Again But… here’s some good news from Tier 1 [more…]
Closing Bell: ASX dips, goldies lead, and Forrestania jumps 140pc on iron ore play
ASX 200 dips amid Wall Street closure for Memorial Day Commodities bounce back; gold stocks rise, uranium falls Forrestania jumps on iron ore play [more…]
Monsters of Rock: Uranium miner tanks after managing director sells 70pc of his shares for $21m
Boss Energy (ASX:BOE) managing director/ CEO, chairman and director sell a massive portion of their respective shareholdings on market MD Duncan Craib makes over $21m [more…]
Alma Metals all set to drill Briggs, already one of Australia’s largest copper-molybdenum deposits
Alma Metals secures drill contractor for resource upgrade drilling at its Briggs copper JV Contractor iDrilling Australia will take part of its fees – up [more…]
ASX Small Caps Lunch Wrap: Which 81-year-old’s balls have landed him in jail this week?
Local markets were a bit directionless this morning, in a morning of contrasts on the bourse that saw the benchmark ASX 200 wobble to an [more…]
NickelX appoints new MD to oversee uranium exploration
Special report: NickelX hires new managing director Peter Woods as the company looks to consolidate its focus on uranium and gold exploration. NickelX (ASX:NKL) is [more…]
Resources Top 5: Forrestania neighbours up to MinRes for iron ore, surges 200 pc
Forrestania Resources leads the way today, eyeing up iron ore with a new WA acquisition Falcon Metals is flying on a high-grade mineral sands discovery [more…]
Summit Minerals raises $2m in oversubscribed placement to fast track Brazilian niobium-rare earths push
Summit Minerals has completed a $2mn placement to existing and new domestic and international investors Funds will be spent towards exploration activities at Equador and [more…]
ASX Health Stocks: PainChek wins European patent; Phase 3 Trial set to begin for Opthea
PainChek granted patent in Europe PainChek (ASX:PCK) has been granted a patent in 20 European nations by the European Patent Office (EPO). The patent was [more…]
Bioxyne highlights risks of unregulated psychedelic use
Bioxyne emphasises importance of stringent regulatory frameworks for safe use of psychedelics and cannabis Company highlights risks of incorrect dosages, impure substances, and lack of [more…]
